Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance

Gil-Núñez A, Masjuan J, Montaner J, Castellanos M, Segura T, Cardona P, Tembl JI, Purroy F, Arenillas J, Palacio E. Neurologia (Engl Ed). 2022 Mar;37(2):136-150. doi: 10.1016/j.nrleng.2020.11.014. Epub 2021 Dec 11.PMID: 34906541